Cannabidiol, a naturally occurring chemical found in marijuana plants, is “not likely to be abused or create dependence,” an initial review by the WHO’s Expert Committee on Drug Dependence found.

CNN and other mainstream media outlets are reporting that the WHO have come to the conclusion that international prohibitions against pure cannabidiol are “completely unwarranted”, as it poses no known public health threat.
 A complete review of cannabidiol has been postponed until May 2018.
CNN reports…

Due to increasing worldwide interest in using cannabis and its active ingredients (known as cannabinoids) as medical products, the WHO has begun to gather scientific evidence as it decides whether to place these compounds under international control.

The November committee report explored the therapeutic qualities and side effects of cannabidiol (sometimes known as CBD) in particular.

Several clinical trials demonstrate that pure cannabidiol is an effective treatment for epilepsy, and an experimental product is in Phase 3 trials, the committee report noted.
Preliminary evidence, as well as unsanctioned medical use of CBD-based products sold online, suggests that cannabidiol may offer additional therapeutic benefits.
 “CBD is generally well tolerated with a good safety profile,” the authors of the report wrote. “To date, there is no evidence of recreational use of CBD or any public health related problems associated” with its use.
Click Below To Access The Full Report As A PDF